Last reviewed · How we verify

NCT05975138

Trans-gingival or Subcrestal Short Implants Posterior Maxilla Bone Changes

Completed Last updated 3 August 2023
What this trial tests

trial testing implant insertion in Alveolar Bone Resorption in 22 participants. Completed in 15 July 2023.

Timeline
15 June 2021
Primary endpoint
15 June 2023
15 July 2023

Quick facts

Lead sponsorInternational Piezosurgery Academy
StatusCompleted
Study typeOBSERVATIONAL
Enrollment22
Start date15 June 2021
Primary completion15 June 2023
Estimated completion15 July 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

International Piezosurgery Academy

Who can join

Adults 18 to 99, any sex, with Alveolar Bone Resorption. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

two groups of inserted implants: trans-gingival and under-bone level; difference in the marginal bone loss at six months from placement between the two groups of implant positioned in the posterior atrophic maxilla

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical Outcomes of Bone-Level and Tissue-Level Short Implants Placed in Posterior Maxilla: A Case-Control Study.
    Lombardi T, Rapani A, Ezeddine F, Perazzolo G, et al · · 2025 · cited 4× · PMID 39676168 · DOI 10.1111/cid.13428

Verify or expand the search:

Other trials of implant insertion

Trials testing the same drug.

Other recruiting trials for Alveolar Bone Resorption

Currently open trials in the same condition.

Other International Piezosurgery Academy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05975138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing